Catalyst Wire Dossier Catalyst Wire Dossier

Memory-like natural killer (NK) cell therapy

· Dana-Farber Cancer Institute
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Memory-like natural killer (NK) cell therapy, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Memory-like Natural Killer (NK) Cell Therapy in Patients With Renal Cell Carcinoma or Urothelial Carcinoma [EARLY_Phase 1]

See pricing